Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
64 studies found for:    "Genital Diseases, Female" | Japan
Show Display Options
Rank Status Study
1 Recruiting Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
Condition: Endometriosis
Interventions: Drug: KLH-2109;   Drug: Placebo;   Drug: Leuprorelin acetate
2 Completed A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
Condition: Endometriosis
Intervention: Drug: KLH-2109
3 Completed A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
Condition: Endometriosis
Interventions: Drug: KLH-2109;   Drug: placebo
4 Completed A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)
Condition: Endometriosis
Intervention: Drug: KLH-2109
5 Recruiting A Survey on Efficacy and Safety in Patients With Endometriosis
Condition: Endometriosis
Intervention: Drug: Dydrogesterone
6 Completed A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
Condition: Infertility
Interventions: Drug: FE 999049;   Drug: follitropin beta
7 Unknown  The Effect of Sacral Surface Electrical Stimulation for Assisted Reproductive Technology
Condition: Infertility
Intervention: Device: SSE
8 Unknown  Analysis of Implantation Failure and Establishment of Therapy for Implantation Failure
Condition: Infertility
Intervention:
9 Completed Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery
Conditions: Surgery, Laparoscopic;   Sexual Dysfunction, Physiological;   Colorectal Surgery
Intervention: Procedure: laparoscopic colorectal surgery
10 Completed Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis
Condition: Endometriosis
Interventions: Drug: EE20/DRSP(BAY86-5300);   Drug: Placebo;   Drug: Dienogest
11 Completed Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
Condition: Endometriosis
Interventions: Drug: Placebo;   Drug: TAK-385;   Drug: Leuprorelin acetate
12 Completed A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
Condition: Endometriosis
Interventions: Drug: Placebo;   Drug: TAK-385;   Drug: Leuprorelin acetate
13 Completed Bay98-7196, Dose Finding / POC Study
Condition: Endometriosis
Interventions: Drug: Placebo;   Drug: Levonorgestrel;   Drug: Anastrozole + Levonorgestrel (BAY98-7196);   Drug: Lupron / Leuprolide acetate
14 Completed A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.
Conditions: Primary Ovarian Insufficiency;   Vaginitis;   Metrorrhagia;   Menopause
Interventions: Drug: Premarin reference tablet (fasted);   Drug: Premarin new tablet (fasted);   Drug: Premarin reference tablet (fed);   Drug: Premarin new tablet (fed)
15 Completed
Has Results
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Conditions: Infertility;   Ovulation Induction
Interventions: Drug: Gonalef® (Follitropin alfa);   Drug: Purified pituitary gonadotropin (Fertinorm-P®)
16 Completed OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Intervention: Drug: Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)
17 Recruiting Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
Condition: Menorrhagia, Dysmenorrhea
Intervention: Drug: Mirena (Levonorgestrel IUS, BAY86-5028)
18 Active, not recruiting CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study)
Condition: Cervical Cancer
Interventions: Other: LBC;   Other: LBC plus HPV DNA testing
19 Completed Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Genetic Disorder;   Turner Syndrome
Intervention: Drug: somatropin
20 Unknown  An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Conditions: Small Cell Lung Cancer;   Non-small Cell Lung Cancer;   Cervical Cancer;   Ovarian Cancer;   Gastric Cancer (Inoperable and Recurrent)
Intervention: Drug: CPT-11 and platinum analogues

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.